natgillin/translations-raw huggingface dataset:
Typer A, B, C, D, E, F
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2 P230
Specificér, at det skal holdes væk fra varme.
… Manufacturer/supplier to specify appropriate material.
Spray ikke mod åben ild eller andre antændelseskilder.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P232
Specifik målorgantoksicitet — enkelt eksponering; irritation af luftvejene (punkt 3.8)
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 P234
Selvreaktive stoffer og blandinger (punkt 2.8)
Self-reactive substances and mixtures (Section 2.8)
Beholder og modtageudstyr jordforbindes/potentialudlignes.
Ground/bond container and receiving equipment.
hvis eksplosivet er følsomt over for statisk elektricitet.
if the explosive is electrostatically sensitive.
hvis materialet skal genpåfyldes og er følsomt over for statisk elektricitet.
if electrostatically sensitive material is for reloading.
Anvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.
Use explosion-proof electrical/ventilating/lighting/…/equipment.
Producent/leverandør kan angive andet udstyr.
… Manufacturer/supplier to specify other equipment.
hvis der kan forekomme støvskyer.
if dust clouds can occur.
Anvend kun værktøj, som ikke frembringer gnister.
Use only non-sparking tools.
Træf foranstaltninger mod statisk elektricitet.
Take precautionary measures against static discharge.
Reduktionsventilerne holdes fri for fedt og olie.
Keep reduction valves free from grease and oil.
Må ikke udsættes for slibning/stød/…/gnidning.
Do not subject to grinding/shock/…/friction.
Gruppe 1.1, 1.2, 1.3, 1.4, 1.5
Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … Manufacturer/supplier to specify applicable rough handling. P251
Producent/leverandør angiver den pågældende form for hårdhændet behandling.
Pressurized container: Do not pierce or burn, even after use. Flammable aerosols (section 2.3) 1, 2 P260
Beholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.
Manufacturer/supplier to specify applicable conditions. Specific target organ toxicity — single exposure (section 3.8) 1, 2
Brandfarlige aerosoler (punkt 2.3)
Specific target organ toxicity — repeated exposure (section 3.9) 1, 2
Indånd ikke pulver/røg/gas/tåge/damp/spray.
if inhalable particles of dusts or mists may occur during use. Reproductive toxicity — effects on or via lactation (section 3.7) Additional category P261
Akut toksicitet — indånding (punkt 3.1)
Avoid breathing dust/fume/gas/mist/vapours/spray. Acute toxicity — inhalation (section 3.1)
Producent/leverandør angiver de pågældende forhold.
Manufacturer/supplier to specify applicable conditions. Respiratory sensitisation (section 3.4) 1 Skin sensitisation (section 3.4) 1
hvis produktet er flygtigt, så der dannes en farlig atmosfære.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specifik målorgantoksicitet — gentaget eksponering (punkt 3.9)
1, 2 P263 Avoid contact during pregnancy/while nursing.
1A, 1B, 1C Specificér, at pulvere eller tåger ikke må indåndes.
Manufacturer/supplier to specify parts of the body to be washed after handling.
Hudætsning (punkt 3.2)
Skin corrosion (section 3.2) 1A, 1B, 1C
Hudirritation (punkt 3.2)
Specific target organ toxicity — repeated exposure (section 3.9) 1 P270 Do not eat, drink or smoke when using this product. Acute toxicity — oral (section 3.1)
Specifik målorgantoksicitet — gentaget eksponering (punkt 3.9)
Contaminated work clothing should not be allowed out of the workplace. Skin sensitisation (section 3.4) 1 P273
Brug kun udendørs eller i et rum med god udluftning.
if this is not the intended use. Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1) 1, 2, 3, 4 Hazardous to the ozone layer (section 5.1) 1 P280
Akut toksicitet — indånding (punkt 3.1)
Wear protective gloves/protective clothing/eye protection/face protection. Explosives (section 2.1)
Specifik målorgantoksicitet — enkelt eksponering; irritation af luftvejene (punkt 3.8)
Manufacturer/supplier to specify type of equipment. Specify protective gloves and eye/face protection.
Specifik målorgantoksicitet — enkelt eksponering; narkose (punkt 3.8)
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Pyrophoric liquids (section 2.9) 1
Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3
Hudsensibilisering (punkt 3.4)
Oxidising liquids (section 2.13) 1, 2, 3
Undgå udledning til miljøet.
Types A, B, C, D, E, F Acute toxicity — dermal (section 3.1) 1, 2, 3, 4
Farlig for vandmiljøet — akut fare for vandmiljøet (punkt 4.1)
Manufacturer/supplier to specify type of equipment. Specify protective gloves/clothing.
hvis dette ikke er tilsigtede anvendelse.
1A, 1B, 1C Manufacturer/supplier to specify type of equipment.
Farlig for vandmiljøet — kronisk fare for vandmiljøet (punkt 4.1)
Specify protective gloves/clothing and eye/face protection. Skin irritation (section 3.2) 2
Farlig for ozonlaget (punkt 5.1)
Specify protective gloves. Skin sensitisation (section 3.4)
Bær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse.
Manufacturer/supplier to specify type of equipment. Specify eye/face protection.
Eksplosiver (punkt 2.1)
Eye irritation (section 3.3) 2 P281
Producent/leverandør kan nærmere angive udstyr.
Explosives (section 2.1) Unstable explosive
Kimcellemutagenicitet (punkt 3.5)
Germ cell mutagenicity (section 3.5) 1A, 1B, 2
Brandfarlige væsker (punkt 2.6)
Carcinogenicity (section 3.6) 1A, 1B, 2
Pyrofore faste stoffer (punkt 2.10)
Oxidising solids (section 2.14) 1
Anvend de påkrævede personlige værnemidler.
+ P410 Keep cool.
VED KONTAKT MED TØJET:
IF ON CLOTHING: Oxidising liquids (section 2.13) 1
Brandnærende væsker (punkt 2.13)
Oxidising solids (section 2.14) 1 P307
Brandnærende faste stoffer (punkt 2.14)
Specific target organ toxicity — single exposure (section 3.8) 1 P308
VED eksponering:
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category P309 IF exposed or if you feel unwell:
Akut toksicitet — dermal (punkt 3.1)
1 Aspiration hazard (section 3.10)
Alvorlige øjenskader/øjenirritation (punkt 3.3)
Respiratory sensitisation (section 3.4) 1 Specific target organ toxicity — single exposure (section 3.8) 1, 2 P312
I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
Get medical advice/attention if you feel unwell. Specific target organ toxicity — repeated exposure (section 3.9) 1, 2 P315
Akut toksicitet — oral (punkt 3.1)
Get immediate medical advice/attention. Gases under pressure (section 2.5)
Akut toksicitet — dermal (punkt 3.1)
Specific treatment is urgent (see … on this label). Acute toxicity — inhalation (section 3.1)
Akut toksicitet — indånding (punkt 3.1)
… Reference to supplemental first aid instruction. if immediate administration of antidote is required. P321 Specific treatment (see … on this label).
Specifik målorgantoksicitet — enkelt eksponering; irritation af luftvejene (punkt 3.8)
… Reference to supplemental first aid instruction. if immediate administration of antidote is required. Acute toxicity — inhalation (section 3.1) 3 … Reference to supplemental first aid instruction.
Søg lægehjælp.
if immediate measures are required. Skin sensitisation (section 3.4) 1
Hudirritation (punkt 3.2)
… Reference to supplemental first aid instruction. manufacturer/supplier may specify a cleansing agent if appropriate.
Øjenirritation (punkt 3.3)
1A, 1B, 1C Skin irritation (section 3.2) 2
Hudsensibilisering (punkt 3.4)
Specific measures (see … on this label). Acute toxicity — dermal (section 3.1)
Kimcellemutagenicitet (punkt 3.5)
… Reference to supplemental first aid instruction. if immediate measures such as specific cleansing agent is advised.
1A, 1B, 2
Acute toxicity — dermal (section 3.1) 3, 4
Carcinogenicitet (punkt 3.6)
… Reference to supplemental first aid instruction. if measures such as specific cleansing agent is advised. P330 Rinse mouth.
1A, 1B, 2
Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C P331
Reproduktionstoksicitet (punkt 3.7)
Do NOT induce vomiting. Skin corrosion (section 3.2) 1A, 1B, 1C
1A, 1B, 2
Aspiration hazard (section 3.10) 1 P332
Reproduktionstoksicitet — virkninger på eller via amning (punkt 3.7)
If skin irritation occurs: Skin irritation (section 3.2) 2, 3 P333
Ekstra kategori
If skin irritation or rash occurs: Skin sensitisation (section 3.4) 1
Specifik målorgantoksicitet — gentaget eksponering (punkt 3.9)
Pyrophoric liquids (section 2.9) 1 Pyrophoric solids (section 2.10) 1
Søg omgående lægehjælp.
Pyrophoric solids (section 2.10) 1 Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2 P336 Thaw frosted parts with lukewarm water. Do not rub affected area.
Akut toksicitet — oral (punkt 3.1)
Eye irritation (section 3.3) 2
hvis det er nødvendigt straks at give modgift.
Continue rinsing. Skin corrosion (section 3.2)
Henvisning til supplerende anvisninger om førstehjælp.
Serious eye damage/eye irritation (section 3.3) 1
Akut toksicitet — dermal (punkt 3.1)
Respiratory sensitisation (section 3.4) 1
Henvisning til supplerende anvisninger om førstehjælp.
Gently wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 1, 2
Stoffer og blandinger, som ved kontakt med vand afgiver brandfarlige gasser (punkt 2.12)
Remove/Take off immediately all contaminated clothing. Flammable liquids (section 2.6)
Børst løse partikler bort fra huden.
Acute toxicity — dermal (section 3.1) 1, 2, 3
Stoffer og blandinger, som ved kontakt med vand afgiver brandfarlige gasser (punkt 2.12)
Take off contaminated clothing and wash before reuse. Skin irritation (section 3.2)
Akut toksicitet — indånding (punkt 3.1)
1, 2, 3 Flammable solids (section 2.7)
Ved luftvejssymptomer:
Oxidising solids (section 2.14) 1, 2, 3 P371
Vask forsigtigt med rigeligt sæbe og vand.
Oxidising liquids (section 2.13) 1
Brandfarlige væsker (punkt 2.6)
Flammable liquids (section 2.6) 1, 2, 3
Carcinogenicitet (punkt 3.6)
1A, 1B, 2 Reproductive toxicity (section 3.7)
Opbevares ved en temperatur, som ikke overstiger … oC/…oF.
Store at temperatures not exceeding … oC/…oF.
Producent/leverandør angiver temperatur.
… Manufacturer/supplier to specify temperature
Må ikke udsættes for en temperatur, som overstiger 50 oC/122 oF.
Do not expose to temperatures exceeding 50 oC/122 oF.
Bulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.
Store bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF.
Producent/leverandør angiver masse og temperatur.
… Manufacturer/supplier to specify mass and temperature.
Må ikke opbevares i nærheden af andre materialer.
Store away from other materials.
Må ikke udsættes for en temperatur, som overstiger 50 oC/122 oF.
Do not expose to temperatures exceeding 50 oC/122oF.
Producent/leverandør angiver temperatur.
… Manufacturer/supplier to specify temperature.
Tabel 6.5
Table 6.5
Sikkerhedssætninger, bortskaffelse
Disposal precautionary statements
Bær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse.
Bær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse
Tesponix għal temperatura li teċċedi l-50oC/122oF.
Tesponix għal temperatura li teċċedi l-50 oC/122oF.
Flam Liq.
Flam. Liq.
Flam Sol.
Flam. Sol.
Såfremt de specifikke koncentrationsgrænser for visse kategorier afviger fra de generiske koncentrationsgrænser i bilag I, er de angivet i en separat kolonne sammen med den pågældende klassificering med de samme koder som i punkt 1.1.2.1.1.
Specific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1.
Hvis der ikke er angivet nogen koncentrationsgrænser for en bestemt kategori i dette bilag, anvendes de generiske koncentrationsgrænser fra bilag I til klassificeringen af stoffer, der indeholder urenheder, tilsætningsstoffer eller individuelle bestanddele eller til blandinger.
Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures.
I tilfælde, hvor disse stoffer markedsføres i ustabiliseret form, skal leverandøren angive stoffets navn på etiketten efterfulgt af angivelsen »ikke stabiliseret«.
However, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words ‘non-stabilised’.
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate
O, O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
O,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
O,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
bis(3,5-di-tert-butylsalicylato-O,O2)zinc
bis(3,5-di-tert-butylsalicylato-O1,O2)zinc
dipentene;
limonene; [1]
limonene; [1]
(R)-p-mentha-1,8-diene; d-limonene; [2]
(R)-p-mentha-1,8-diene; d-limonene; [2] (S)-p-mentha-1,8-diene;
(S)-p-mentha-1,8-diene;
6-methyl-1,3-dithiolo(4,5—b)quinoxalin-2-one
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one
(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one
5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone
5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
(E—E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)
(E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25
reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;
N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;
N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride)
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride)
reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H—2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H—2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H—2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate
potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate
4-(4-chlorophenyl)-2-phenyl-2-[(1H—1,2,4-triazol-1-yl)methyl]butanenitrile
4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
α, α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);
α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);
C12-14—tert-alkylamine, methylphosphonic acid salt
C12-14-tert-alkylamine, methylphosphonic acid salt
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine
diaminotoluene, technical product — reaction mass of [2] and [3];
diaminotoluene, technical product - reaction mass of [2] and [3];
1-[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl-1H—1,2.4-triazole
1-[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl-1H-1,2.4-triazole
N-(cyclopropylmethyl)-α, α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine
N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine
5-benzyl-3-furylmethyl (±)-cis—trans-chrysanthemate
5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate
(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;
(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol
2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione
2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione
N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide
N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H—1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide
2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)
2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)
(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole
(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole
(±)-[(R(*),R(*)) and (R(*),S(*))]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
(±)-(R(*),S(*))-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide
N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide
D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
α,α-dimethylbenzyl hydroperoxide;
α, α-dimethylbenzyl hydroperoxide;
bis(α,α-dimethylbenzyl) peroxide
bis(α, α-dimethylbenzyl) peroxide
tert-butyl α,α-dimethylbenzyl peroxide
tert-butyl α, α-dimethylbenzyl peroxide
[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
zinc bis dimethyldithiocarbamate
zinc bis dimethyldithiocarbamate
C; R35
R35 O; C
[R-(R(*),S(*))]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt
[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt
ethoxylated bis phenol A di-(norbornene carboxylate)
ethoxylated bis phenol A di-(norbornene carboxylate)
Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt
Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt
N—tert-pentyl-2-benzothiazolesulfenamide
N-tert-pentyl-2-benzothiazolesulfenamide
trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate
trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate
N—tert-butyl-3-methylpicolinamide
N-tert-butyl-3-methylpicolinamide
α, α-dimethylbenzyl hydroperoxide;
α,α-dimethylbenzyl hydroperoxide;
bis(α, α-dimethylbenzyl) peroxide
bis(α,α-dimethylbenzyl) peroxide
tert-butyl α, α-dimethylbenzyl peroxide
tert-butyl α,α-dimethylbenzyl peroxide
⊗⊗ Carc.
⊗ ⊗ Carc.
(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol
(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
Self-react.. CD
Self-react. CD
væske
liquid Pyr.
Pyr.
Liq.
Aquatic Acute akut 1
Aquatic Acute 1
Berigtigelse til Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 af 16. december 2008 om klassificering, mærkning og emballering af stoffer og blandinger og om ændring og ophævelse af direktiv 67/548/EØF og 1999/45/EF og om ændring af forordning (EF) nr. 1907/2006
Corrigendum to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006
(Den Europæiske Unions Tidende L 353 af 31. december 2008) Side 331, bilag VI, punkt 1.1.2.1.1, tabel 1.1: I stedet for: »Brandfarlig væske Flam. Liq. 1 Flam. Liq. 2 Flam Liq. 3 Brandfarligt fast stof Flam. Sol. 1 Flam Sol. 2« læses: »Brandfarlig væske Flam. Liq. 1 Flam. Liq. 2 Flam. Liq. 3 Brandfarligt fast stof Flam. Sol. 1 Flam. Sol. 2« Side 331, bilag VI, punkt 1.1.2.1.1, tabel 1.1: I stedet for: »Selvopvarmende stof eller blanding Self-heat. 1 Self-heat 2« læses: »Selvopvarmende stof eller blanding Self-heat. 1 Self-heat. 2« Side 331, bilag VI, punkt 1.1.2.1.1, tabel 1.1: I stedet for: »Akut toksicitet Acute tox. 1 Acute tox. 2 Acute tox. 3 Acute tox 4« læses: »Akut toksicitet Acute tox. 1 Acute tox. 2 Acute tox. 3 Acute tox. 4« Side 1352, bilag VII, punkt 1, tabel 1.1: I stedet for: »F+; R12 væske Self-react.. CD H242 Self-react. EF H242 Self-react. G ingen« læses: »F+; R12 væske Self-react. CD H242 Self-react. EF H242 Self-react. G ingen«
(Official Journal of the European Union L 353 of 31 December 2008)
Side 1354, bilag VII, punkt 1, tabel 1.1: I stedet for:
On page 1354, Annex VII, point 1, Table 1.1:
»N; R50 – 53
for:
Aquatic Acute 1
‘N; R50
læses:
H400’
»N; R50 – 53
read:
Aquatic Chronic 1
Aquatic.
H400 H410«
Acute 1
Aquatic Chronic 1 H400
Aquatic Acute 1
Kommissionens forordning (EF) nr. 1273/2008
Commission Regulation (EC) No 1273/2008
Denne forordning træder i kraft den 18. december 2008.
This Regulation shall enter into force on 18 December 2008.
Kommissionens forordning (EF) nr. 1274/2008
Commission Regulation (EC) No 1274/2008
om ændring af forordning (EF) nr. 1126/2008 om vedtagelse af visse internationale regnskabsstandarder i overensstemmelse med Europa-Parlamentets og Rådets forordning (EF) nr. 1606/2002 for så vidt angår IAS 1
amending Regulation (EC) No 1126/2008 adopting certain international accounting standards in accordance with Regulation (EC) No 1606/2002 of the European Parliament and of the Council as regards International Accounting Standard (IAS) 1